Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

It has been known for more than 60 years, and suspected for over 100, that alveolar hypoxia
causes pulmonary vasoconstriction by means of mechanisms local to the lung. For the last …

6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

Mild-to-moderate pulmonary hypertension is a common complication of chronic obstructive
pulmonary disease (COPD); such a complication is associated with increased risks of …

Pulmonary atelectasis is common in the perioperative period. Physiologically, it is produced
when collapsing forces derived from positive pleural pressure and surface tension overcome …

Pulmonary hypertension is a common complication of chronic obstructive pulmonary
disease (COPD). Its presence is associated with shorter survival and worse clinical …

Background. Exaggerated pulmonary-artery pressure due to hypoxic vasoconstriction is
considered an important pathogenetic factor in high-altitude pulmonary edema. We …

Pulmonary hypertension during exercise is common in severe chronic obstructive
pulmonary disease (COPD). It was hypothesised that the use of the endothelin-receptor …

Nifedipine 1 is an antagonist of calcium influx through the slow channel of the cell
membrane and has been shown to be an effective and relatively well-tolerated treatment for …

Even mild pulmonary hypertension (PH) is associated with increased mortality and morbidity
in patients with chronic obstructive pulmonary disease (COPD). However, the underlying …